Gasdermin D Is a Novel Prognostic Biomarker and Relates to TMZ Response in Glioblastoma.

Cancers (Basel) · 2021 · PMC8616249 · PMID 34830775

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The median survival time of GBM patients with high GSDMD expression showed a trend to those with low GSDMD expression (632 days vs. 356 days), but was not statistically significant ( p = 0.05) ( Figure 8 G,H). 4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.